Cargando…

Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signaling

BACKGROUND: Our previous study revealed the extract from the bark of an Amazonian tree Pao Pereira can suppress benign prostatic hyperplasia (BPH) in a rat model. Herein, we examined its inhibitory effects on human BPH cells and dissect its molecular mechanism. METHODS: We applied Pao extract to hum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yu, Liu, Jiakuan, Xue, Zesheng, Sun, Jingya, Huang, Zhengnan, Jing, Yifeng, Han, Bangmin, Shen, Bing, Yan, Jun, Huang, Ruimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231430/ https://www.ncbi.nlm.nih.gov/pubmed/32416730 http://dx.doi.org/10.1186/s12906-020-02943-2

Ejemplares similares

Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase
por: Liu, Jiakuan, et al.
Publicado: (2019)

Rauwolfia vomitoria extract suppresses benign prostatic hyperplasia by inducing autophagic apoptosis through endoplasmic reticulum stress
por: Huang, Guifang, et al.
Publicado: (2022)

P01.38. Anti-cancer activity of extracts from Rauwolfia vomitoria and Pao Pereira
por: Yu, J, et al.
Publicado: (2012)

Extract of the Medicinal Plant Pao Pereira Inhibits Pancreatic Cancer Stem-Like Cell In Vitro and In Vivo
por: Dong, Ruochen, et al.
Publicado: (2018)

Extracts of the Medicinal Plants Pao Pereira and Rauwolfia vomitoria Inhibit Ovarian Cancer Stem Cells In Vitro
por: Chen, Ping, et al.
Publicado: (2022)

A Modified Technique of Thulium Laser Enucleation for Benign Prostatic Hyperplasia With Non-morcellator Approach
por: Jing, Yifeng, et al.
Publicado: (2021)

Victor Pereira
por: Marwaha, Seema
Publicado: (2021)

Death of Pereira
Publicado: (1853)

Solórzano Pereira : antología
Publicado: (1942)

Suppression of benign prostate hyperplasia by Kaempferia parviflora rhizome
por: Murata, Kazuya, et al.
Publicado: (2013)

Sostiene Pereira : una declaración
por: Tabucchi, Antonio, 1943-2012

Sostiene Pereira : una declaración /
por: Tabucchi, Antonio, 1943-2012
Publicado: (2019)

Sostiene Pereira : una declaración
por: Tabucchi, Antonio 1943-
Publicado: (1998)

Benign Prostatic Hyperplasia
Publicado: (2015)

Dr. C. Pereira
Publicado: (1911)

Death of Dr. Pereira
Publicado: (1853)

Pereira’s Materia Medica
Publicado: (1854)

Rapamycin and Low-dose IL-2 Mediate an Immunosuppressive Microenvironment to Inhibit Benign Prostatic Hyperplasia
por: Cao, Tianyu, et al.
Publicado: (2023)

Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia
por: D’Amico, Ramona, et al.
Publicado: (2021)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Qianliexin capsule exerts anti‐inflammatory activity in chronic non‐bacterial prostatitis and benign prostatic hyperplasia via NF‐κB and inflammasome
por: Zang, Linghe, et al.
Publicado: (2021)

Dr. Pereira's Materia Medica
Publicado: (1873)

Hélio Pereira de Magalhães
por: Galantier, Maurício
Publicado: (2016)

First person – Matthew T. Pereira
Publicado: (2018)

Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB
por: Jin, Bo-Ram, et al.
Publicado: (2021)

PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7
por: Huang, Zhengnan, et al.
Publicado: (2021)

Piceatannol Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Modulation of Nrf2/HO-1/NFκB Axis
por: Eid, Basma G., et al.
Publicado: (2020)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells
por: Han, Yangyang, et al.
Publicado: (2017)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Effects of inflammatory responses, apoptosis, and STAT3/NF-κB- and Nrf2-mediated oxidative stress on benign prostatic hyperplasia induced by a high-fat diet
por: Li, Yongzhi, et al.
Publicado: (2019)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling
por: Huang, Zhengnan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9q5p80rfa2g27405puk330l9f2